Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
10726
CALL
Watts Water Technologies
WTS
$12.8B
| $163K | ﹤0.01% |
800
-400
| -33% | -$83.1K |
|
10727
Optex Systems
OPXS
$79.1M
| $162K | ﹤0.01% |
23,664
+4,431
| +23% | +$37.2K |
|
|
ETHU
10728
2x Ether ETF
ETHU
$712M
| $162K | ﹤0.01% |
+1,041
| New | +$156K |
|
10729
Radiant Logistics
RLGT
$408M
| $162K | ﹤0.01% |
24,226
+18,874
| +353% | +$130K |
|
10730
CALL
Yext
YEXT
$594M
| $162K | ﹤0.01% |
25,500
-20,600
| -45% | -$150K |
|
|
MTLS
10731
CALL
Materialise
MTLS
$400M
| $162K | ﹤0.01% |
23,000
+21,800
| +1,817% | +$144K |
|
10732
PUT
Pathward Financial
CASH
$1.8B
| $162K | ﹤0.01% |
2,200
-5,100
| -70% | -$389K |
|
10733
CALL
Veru
VERU
$46.5M
| $162K | ﹤0.01% |
24,880
+14,610
| +142% | +$108K |
|
10734
CALL
Gogo Inc
GOGO
$383M
| $162K | ﹤0.01% |
20,000
-139,500
| -87% | -$1.04M |
|
10735
PUT
Stepan Co
SCL
$1.48B
| $162K | ﹤0.01% |
2,500
+1,900
| +317% | +$141K |
|
|
BAND
10736
PUT
Bandwidth Inc
BAND
$1.74B
| $162K | ﹤0.01% |
9,500
-14,600
| -61% | -$274K |
|
10737
SkinHealth Systems
SKIN
$86.8M
| $162K | ﹤0.01% |
+101,611
| New | +$160K |
|
10738
CALL
Crescent Capital BDC
CCAP
$411M
| $161K | ﹤0.01% |
8,400
-18,000
| -68% | -$340K |
|
10739
Astrotech Corp
ASTC
$16.9M
| $161K | ﹤0.01% |
24,014
+9,256
| +63% | +$68.7K |
|
10740
Culp Inc
CULP
$42.1M
| $161K | ﹤0.01% |
27,441
+7,286
| +36% | +$39.8K |
|
10741
PUT
VistaGen Therapeutics
VTGN
$11.9M
| $161K | ﹤0.01% |
54,600
-900
| -2% | -$2.53K |
|
10742
PUT
Fortress Biotech
FBIO
$97.7M
| $161K | ﹤0.01% |
79,400
+71,700
| +931% | +$130K |
|
|
BGDE
10743
Big Digital Energy Inc
BGDE
$37.7M
| $161K | ﹤0.01% |
+9,650
| New | +$281K |
|
10744
CALL
Spyre Therapeutics
SYRE
$9.14B
| $161K | ﹤0.01% |
6,900
+6,300
| +1,050% | +$185K |
|
10745
CALL
HUB Group
HUBG
$2.46B
| $160K | ﹤0.01% |
3,600
-21,200
| -85% | -$989K |
|
10746
CALL
ProShares UltraShort FTSE Europe
EPV
$10.2M
| $160K | ﹤0.01% |
+3,860
| New | +$148K |
|
10747
Veralto
VLTO
$23.8B
| $160K | ﹤0.01% |
1,573
-670,725
| -100% | -$71.5M |
|
|
SHCO
10748
CALL
DELISTED
Soho House & Co
SHCO
| $160K | ﹤0.01% |
21,500
+11,300
| +111% | +$61.5K |
|
10749
Cato Corp
CATO
$67.9M
| $160K | ﹤0.01% |
41,056
+22,331
| +119% | +$109K |
|
10750
Globus Maritime Ltd
GLBS
$78.6M
| $160K | ﹤0.01% |
136,737
+10,772
| +9% | +$16.5K |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.